Purity | Size | Price | VIP Price | USA Stock *0-1 Day | Global Stock *5-7 Days | Quantity | |||||
{[ item.p_purity ]} | {[ item.pr_size ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} | Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_usd,1,item.mem_rate) ]} | {[ item.pr_usastock ]} | Inquiry - | {[ item.pr_chinastock ]} | Inquiry - |
* Storage: {[proInfo.prStorage]}
CAS No. : | 25199-84-2 | MDL No. : | MFCD03407380 |
Formula : | C10H6F3NO | Boiling Point : | - |
Linear Structure Formula : | - | InChI Key : | UUROBWTVZZNDFD-UHFFFAOYSA-N |
M.W : | 213.16 | Pubchem ID : | 2759347 |
Synonyms : |
|
Num. heavy atoms : | 15 |
Num. arom. heavy atoms : | 10 |
Fraction Csp3 : | 0.1 |
Num. rotatable bonds : | 1 |
Num. H-bond acceptors : | 5.0 |
Num. H-bond donors : | 1.0 |
Molar Refractivity : | 48.77 |
TPSA : | 33.12 Ų |
GI absorption : | High |
BBB permeant : | Yes |
P-gp substrate : | No |
CYP1A2 inhibitor : | Yes |
CYP2C19 inhibitor : | No |
CYP2C9 inhibitor : | No |
CYP2D6 inhibitor : | No |
CYP3A4 inhibitor : | No |
Log Kp (skin permeation) : | -5.43 cm/s |
Log Po/w (iLOGP) : | 1.95 |
Log Po/w (XLOGP3) : | 3.05 |
Log Po/w (WLOGP) : | 4.11 |
Log Po/w (MLOGP) : | 2.6 |
Log Po/w (SILICOS-IT) : | 2.92 |
Consensus Log Po/w : | 2.93 |
Lipinski : | 0.0 |
Ghose : | None |
Veber : | 0.0 |
Egan : | 0.0 |
Muegge : | 0.0 |
Bioavailability Score : | 0.55 |
Log S (ESOL) : | -3.51 |
Solubility : | 0.0658 mg/ml ; 0.000309 mol/l |
Class : | Soluble |
Log S (Ali) : | -3.41 |
Solubility : | 0.0826 mg/ml ; 0.000388 mol/l |
Class : | Soluble |
Log S (SILICOS-IT) : | -4.02 |
Solubility : | 0.0204 mg/ml ; 0.0000957 mol/l |
Class : | Moderately soluble |
PAINS : | 0.0 alert |
Brenk : | 0.0 alert |
Leadlikeness : | 1.0 |
Synthetic accessibility : | 1.58 |
Signal Word: | Warning | Class: | N/A |
Precautionary Statements: | P261-P305+P351+P338 | UN#: | N/A |
Hazard Statements: | H315-H319-H335 | Packing Group: | N/A |
GHS Pictogram: |
* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
46.5% | Stage #1: at 110℃; for 1 h; Stage #2: With sulfuric acid In water at 90℃; for 1 h; |
A mixture of aniline (9.30 g, 100 mmol) and ethyl 4,4,4-trifluoro-3-oxobutanoate (36.8 g, 200 mmol) was stirred at 110 °C for 1 hour. The reaction mixture was concentrated under reduced pressure, and then diluted with water (20 mL). Conc. H2S04 (110 g, 1.13 mol) was added carefully and the mixture stirred at 90°C forhour, then cooled to room temperature and poured into ice water (500 mL). The precipitate was collected by filtration, and then recrystallised from ethanol (50 mL) to give the title compound (9.90 g, 46.5percent yield) as a white solid. ‘H NMR (400 MHz, DMSO-d6): 12.34 (bs, 1H), 7.75 (m, 2H), 7.45 (d, 1H), 7.32 (m, 1H), 6.99 (s, 1H). MS mlz 214.20 [M+Hjt |
[ 324-32-3 ]
2-Methyl-7-(trifluoromethyl)quinoline
Similarity: 0.75
[ 483-69-2 ]
5-(Trifluoromethyl)quinolin-8-amine
Similarity: 0.75
[ 852062-05-6 ]
2-Chloro-7-methoxy-4-(trifluoromethyl)quinoline
Similarity: 0.73
[ 71082-51-4 ]
7-(Trifluoromethyl)quinoline-3-carboxylic acid
Similarity: 0.72
[ 50650-59-4 ]
4-(Trifluoromethyl)pyridin-2-ol
Similarity: 0.68
[ 84906-81-0 ]
2-Hydroxyquinoline-4-carboxylic acid
Similarity: 0.67
[ 324-32-3 ]
2-Methyl-7-(trifluoromethyl)quinoline
Similarity: 0.75
[ 483-69-2 ]
5-(Trifluoromethyl)quinolin-8-amine
Similarity: 0.75
[ 852062-05-6 ]
2-Chloro-7-methoxy-4-(trifluoromethyl)quinoline
Similarity: 0.73
[ 71082-51-4 ]
7-(Trifluoromethyl)quinoline-3-carboxylic acid
Similarity: 0.72
[ 324-32-3 ]
2-Methyl-7-(trifluoromethyl)quinoline
Similarity: 0.75
[ 483-69-2 ]
5-(Trifluoromethyl)quinolin-8-amine
Similarity: 0.75
[ 852062-05-6 ]
2-Chloro-7-methoxy-4-(trifluoromethyl)quinoline
Similarity: 0.73